EASTMAN CHEMICAL CO (EMN) Form 10-Q — Oct 30, 2026
Eastman Chemical posted a sharp earnings recovery in Q3 2026, with sales up 8% to $2,385 million and diluted EPS of $2.19 versus just $0.60 a year ago; adjusted diluted EPS was $1.84 versus $1.14, driven by higher selling prices, improved asset utilization, and lower planned maintenance costs. The Chemical Intermediates segment was a standout, swinging to $35 million of EBIT from $1 million as tight market conditions tied to the Middle East conflict boosted olefin pricing, while Advanced Materials EBIT ex-non-core rose 94% on roughly $60 million of improved asset utilization. The Fibers segment remained the weak spot, with nine-month sales down 11% on lower acetate tow pricing.
Key figures
- Eps
- 2.19
- Revenue
- 2385000000
- Guidance
- 2026 capital expenditures expected to be approximately $400 million, primarily maintenance capital
- Net Income
- 252000000
- Total Debt
- 5218000000
- Revenue Yoy
- 8% (Q3 2026 vs Q3 2025); 4% for first nine months ($7,075M vs $6,779M)
- Total Assets
- 15466000000
- Cash Position
- 768000000
- Shares Outstanding
- 114380456
- Net debt sept 2026
- 4450000000
- Q3 ebit ex noncore
- 305000000
- Q3 2025 diluted eps
- 0.6
- Q3 ebit ex noncore 2025
- 210000000
- Shares repurchased 2026
- 0
- Dividend per share q3 2026
- 0.84
- Ieepa tariff refund benefit
- 24000000
- Nine month diluted eps 2026
- 4.7
- Nine month net earnings 2026
- 542000000
- Q3 2025 adjusted diluted eps
- 1.14
- Q3 2026 adjusted diluted eps
- 1.84
- Operating cash flow nine months 2026
- 377000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.